Review highlights lack of consistency in FDA’s ‘close call’ approvals

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy